Conscious sedation study for left atrial appendage closure
Part of Heart & circulation clinical trials.
This trial tests a left atrial appendage closure device for people with atrial fibrillation who need an alternative to long-term blood thinners. It aims to see if the procedure can be done safely with conscious sedation instead of general anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and have atrial fibrillation that is not caused by a heart valve problem.
- You have a high risk of stroke, as determined by your doctor using a standard risk score.
- You and your doctor have decided that a non-drug treatment for stroke prevention is right for you.
- You are able to take blood thinners for a short time but not for the long term.
- You do not have any medical conditions that would make the procedure unsafe, such as certain heart or lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a simpler procedure to the standard one for closing the left atrial appendage in people with non-valvular atrial fibrillation. The goal is to see which approach works better for preventing strokes while lowering bleeding risks.
This trial compares deep sedation methods during catheter ablation for atrial fibrillation. It aims to find which sedation approach is safer and more comfortable for people with AF who have not had this procedure before.
This trial studies a way to help protect the brain during a catheter procedure that closes the left atrial appendage (a small heart pouch) in people with atrial fibrillation. It may help lower the risk of stroke-related brain injury for patients who can’t safely take blood thinners.
This trial tests a new device called ENDOMATIC SEPIOLA that closes a small pouch in your heart (the left atrial appendage) to lower your stroke risk. It is a non-surgical option for people with atrial fibrillation who cannot take blood thinners.
This trial tests a new device (LAmbre Plus) that closes off a small pouch in the heart (left atrial appendage) to reduce stroke risk in people with AFib who cannot take blood thinners long-term. The procedure is an alternative to daily medication.
This study looks at how different imaging tests can help guide a procedure that closes off the left atrial appendage to reduce stroke risk. It may help doctors choose the safest approach during the procedure.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.